MicroRNA-340 suppresses pancreatic cancer growth by targeting BICD2.
Increasing researches found crucial roles of microRNAs (miRNAs) in malignant tumor progression. In various cancers, miR-340 was low-expressed and served as an independent marker for predicting survival of patients with pancreatic cancer. However, the functions and molecular mechanisms of miRNA-340 in pancreatic cancer (PC) remain unclear. MiR-340 was downregulated in pancreatic cancer cell lines and tissues, and its high-expression suppressed pancreatic cancer cell growth. Then motor adaptor protein BICD2 was identified and proved as one target of miR-340, which was up-regulated in pancreatic cancer tissues and cell lines. However, knockdown of BICD2 significantly weakened cancer cell growth. In vivo experiments further confirmed that miR-340 restoration could reduce tumor size, Ki-67 positive ratio and BICD2 expression, indicating its anti-tumor effects. Altogether, these findings indicated that miR-340 exerted suppressor on cell growth by targeting BICD2 in pancreatic cancer and miR-340/BICD2 axis could be used as a candidate target to treat pancreatic cancer.